Longitudinal study of use and cost of subacromial decompression surgery:the need for effective evaluation of surgical procedures to prevent overtreatment and wasted resources by Jones, Tim et al.
                          Jones, T., Carr, A. J., Beard, D., Linton, M. J., Rooshenas, L., Donovan, J., &
Hollingworth, W. (2019). Longitudinal study of use and cost of subacromial
decompression surgery: the need for effective evaluation of surgical
procedures to prevent overtreatment and wasted resources. BMJ Open, 9,
[e030229]. https://doi.org/10.1136/bmjopen-2019-030229
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1136/bmjopen-2019-030229
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via BMJ Publishing
Group at https://bmjopen.bmj.com/content/9/8/e030229 . Please refer to any applicable terms of use of the
publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
1Jones T, et al. BMJ Open 2019;9:e030229. doi:10.1136/bmjopen-2019-030229
Open access 
Longitudinal study of use and cost of 
subacromial decompression surgery: the 
need for effective evaluation of surgical 
procedures to prevent overtreatment and 
wasted resources
Tim Jones,   1,2 Andrew J Carr,3 David Beard,3 Myles-Jay Linton,1,2 
Leila Rooshenas,2 Jenny Donovan,1,2 William Hollingworth1,2
To cite: Jones T, Carr AJ, 
Beard D, et al.  Longitudinal 
study of use and cost of 
subacromial decompression 
surgery: the need for 
effective evaluation of 
surgical procedures to 
prevent overtreatment and 
wasted resources. BMJ Open 
2019;9:e030229. doi:10.1136/
bmjopen-2019-030229
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
030229).
Received 05 March 2019
Revised 01 July 2019
Accepted 25 July 2019
1The National Institute for Health 
Research Collaboration for 
Leadership in Applied Health 
Research and Care West (NIHR 
CLAHRC West), University 
Hospitals Bristol NHS Foundation 
Trust, Bristol, UK
2Population Health Sciences, 
University of Bristol, Bristol, UK
3Nuffield Department of 
Orthopaedics, Rheumatology 
and Musculoskeletal Sciences, 
University of Oxford, Botany 
Research Centre, Oxford, UK
Correspondence to
Dr Tim Jones;  
 Timothy. Jones@ bristol. ac. uk
Research
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY. 
Published by BMJ.
Strengths and limitations of this study
 ► Our study used a national, longitudinal data set over 
a 10 year period covering all National Health Service 
(NHS) secondary care providers in England, and pri-
vate provision for NHS-funded patients.
 ► Hospital Episode Statistics are linked to hospital 
payments, which is a strong incentive to provide 
complete data, and allowed us to explore costs of 
subacromial decompression in England.
 ► We provide international comparisons of the use of 
subacromial decompression surgery.
 ► Our data are from 2007/2008 onwards, so we un-
derestimate the amount spent on subacromial de-
compression prior to publication of major clinical 
trial results (Can Shoulder Arthroscopy Work (CSAW) 
and Finnish Subacromial Impingement Arthroscopy 
Controlled Trial (FIMPACT)).
 ► There may be additional factors influencing surgery 
rates which we have not controlled for (eg, private 
health insurance coverage).
AbStrACt
Objectives To illustrate the need for better evaluation 
of surgical procedures, we investigated the use and cost 
of subacromial decompression in England over the last 
decade compared with other countries and explored how 
this related to the conduct and outcomes of randomised, 
placebo-controlled clinical trials.
Design Longitudinal observational study using Hospital 
Episode Statistics linked to Payment by Results tariffs in 
England, 2007/2008 to 2016/2017.
Setting Hospital care in England; Finland; New York State, 
USA; Florida State, USA and Western Australia.
Participants Patients with subacromial shoulder pain.
Interventions Subacromial decompression.
Main outcome measures National procedure rates, costs 
and variation between clinical commissioning groups in 
England.
results Without robust clinical evidence, the use of 
subacromial decompression in England increased by 
91% from 15 112 procedures (30 per 100 000 population) 
in 2007/2008, to 28 802 procedures (52 per 100 000 
population) in 2016/2017, costing over £125 million per 
year. Rates of use of subacromial decompression are even 
higher internationally: Finland (131 per 100 000 in 2011), 
Florida State (130 per 100 000 in 2007), Western Australia 
(115 per 100 000 in 2013) and New York State (102 per 
100 000 in 2006). Two randomised placebo-controlled 
trials have recently (2018) shown the procedure to be no 
more effective than placebo or conservative approaches. 
Health systems appear unable to avoid the rapid 
widespread use of procedures of unknown effectiveness, 
and methods for ceasing ineffective treatments are under-
developed.
Conclusions Without good evidence, nearly 30 000 
subacromial decompression procedures have been 
commissioned each year in England, costing over £1 billion 
since 2007/2008. Even higher rates of procedures are 
carried out in countries with less regulated health systems. 
High quality randomised trials need to be initiated before 
widespread adoption of promising operative procedures to 
avoid overtreatment and wasted resources, and methods 
to prevent or desist the use of ineffective procedures need 
to be expedited.
IntrODuCtIOn
Health and social care services are ‘straining 
at the seams’ following increasing demand 
for services from an ageing population with 
more complex needs.1 In England, over 200 
clinical commissioning groups (CCGs) have 
a budget to purchase health services for their 
local populations.2 Hospital care currently 
accounts for 48.5% (£74 billion) of government 
health expenditure in the UK.3 It is vital that 
commissioners make evidence-based decisions 
to maximise the effectiveness of this hospital 
care budget to benefit the overall health of the 
population.
Medicines must be licensed for use for a 
particular condition, requiring pharmaceutical 
companies to provide evidence of effectiveness 
from clinical trials to relevant agencies such 
as the Medicines and Healthcare products 
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Figure 1 ICD-10 and OPCS-4 codes used to define 
subacromial decompression.13 ICD-10, International 
Classification of Diseases - version 10;OPCS-4, Office of 
Population, Censuses and Surveys- fourth revision.
Regulatory Agency in the UK,4 European Medicines Agency 
in the European Union or the Food and Drug Administra-
tion in the USA.5 In the UK, the National Institute for Health 
and Care Excellence (NICE) also evaluates the cost-effective-
ness of many medicines and does not recommend those 
which do not provide value. These regulatory processes have 
their limitations,6 but require robust evidence for the intro-
duction of new treatments. The quality of evidence required 
to introduce new surgical procedures is not as strict as for 
medicines,4 5 in part because no specific product such as a 
drug or device is involved; it can be difficult to categorise 
procedures as ‘new’ rather than modifications and outcomes 
may depend on the skill of the practitioner as well as the 
procedure itself.4 Once introduced, use of procedures can 
spread by clinical consensus,5 and established practice and 
clinical evidence often take many years to be updated.7 8
National Health Service (NHS) England has recently 
commissioned a consultation regarding the use of 17 
hospital procedures,9 one of which is subacromial decom-
pression for shoulder pain. Shoulder pain is common, with 
a lifetime prevalence of up to 66.7%.10 Most of these cases 
(up to 70%) are related to rotator cuff tears or subacromial 
pain.11 Subacromial pain is often considered to be caused by 
bony ‘spurs’ forming on the acromion, part of the shoulder 
blade, leading to inflammation in the surrounding bursa 
and tendons.12 13 Subacromial decompression removes the 
bony spur on the acromion and releases the coracohumeral 
ligament.13 14 There has been a rapidly increasing use of 
subacromial decompression in England, with over 21 000 
procedures carried out in 2009/2010.13
Several randomised controlled trials (RCTs) since the early 
1990s have compared subacromial decompression to non-op-
erative treatment (eg, exercise) for shoulder pain and found 
no evidence of effectiveness.15–17 Two recent multicentre 
RCTs including a placebo surgery arm have further ques-
tioned the effectiveness of subacromial decompression for 
shoulder pain.18 19 The CSAW trial,12 18 recruiting in England 
from 2012 to 2015, compared arthroscopic subacromial 
decompression surgery, placebo (investigational shoulder 
arthroscopy) and no treatment.18 It found no difference in 
shoulder function after 6 months between the arthroscopic 
subacromial decompression group and the arthroscopy 
only (placebo) group, with a small, non-clinically signifi-
cant benefit of surgery over the no treatment control. The 
FIMPACT trial,19 recruiting in Finland from 2005 to 2013, 
compared subacromial decompression with placebo surgery 
and exercise therapy and echoed the results of CSAW, 
extending them to 2 years follow-up. A recent Cochrane 
review including CSAW, FIMPACT and earlier RCTs, found 
high-certainty evidence that subacromial decompression 
does not improve pain, function or health-related quality of 
life.20 This seriously questions whether the resources invested 
in subacromial decompression represent good value for 
money for the NHS. As a result, a recent BMJ article made 
a strong recommendation against subacromial decompres-
sion surgery for chronic shoulder pain.21
In this study we use subacromial decompression for 
shoulder pain as an example to explore the relationship 
between evolving evidence and clinical practice for hospital 
procedures, including how many procedures were performed 
over the last 10 years and how much money was spent before 
RCT evidence raised questions about the procedure’s value; 
how procedure rates compare to other countries and how 
the NHS might reduce the numbers of these procedures.
MethODS
Data sources
Subacromial decompression procedures were identified 
using the ‘admitted patient care’ hospital episode statistics 
(HES-APC). HES is a routinely collected data set that records 
all episodes of care provided to patients admitted (day case 
or inpatient) to NHS hospitals in England and NHS-funded 
patients treated in the independent sector.22 23 Each episode 
in HES represents a period of care under one consultant 
team. Up to 20 diagnoses are recorded per episode using the 
International Classification of Diseases (ICD) version 10. Up 
to 24 clinical procedures per episode may be recorded using 
Office of Population, Censuses and Surveys (OPCS) (fourth 
revision) codes. HES also includes the Lower Super Output 
Area of residence for each patient.24
Identifying subacromial decompression
We extracted anonymised, individual episodes in the 
HES-APC (2007/2008 to 2016/2017) data set. We used diag-
nosis and procedure codes13 (figure 1) to identify subacro-
mial decompression. A small number of patients received 
multiple shoulder procedure episodes on the same day 
(0.3% of all episodes). When these were for the same proce-
dure with the same laterality (0.25% of all episodes), we 
assumed coding error duplication so excluded the episodes. 
If a procedure was marked as bilateral (0.6%), this was 
counted as two procedures. We excluded patients who were 
not resident in England.
estimating procedure rates
National trends over time were estimated using directly stan-
dardised procedure rates25 (per 100 000 population), with 
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Figure 2 Directly standardised rates (per 100 000 people) of 
subacromial decompression in England; Finland; New York 
State, USA; Florida State, USA and Western Australia notes 
for figure 2. England data prior to 2007 is taken from Judge et 
al.13; New York State data is for subacromial decompression 
with or without rotator cuff repair, while data for Florida 
State, Finland and Western Australia is for subacromial 
decompression alone.37–40
Table 1 Descriptive information for subacromial 
decompression patients, 2007/2008 and 2016/2017
2007/08 2016/17
Procedure count 15 112 28 802
% Women 51.0 52.0
Age in years (SD) 54.94 (12.55) 54.89 (12.39)
% Arthroscopy 39.0 94.1
% Independent 
providers
2.4 31.9
% Day-case 51.0 79.3
the population of England in 2016 as our standard popu-
lation. For comparison of smaller areas, we estimated indi-
rectly standardised rates26 per 100 000 population, using the 
same standard population, and adjusting for deprivation 
and ethnicity (see online supplementary appendix A for 
more details).
estimating procedure costs
Costs were estimated for each financial year by linking 
Healthcare Resource Group codes for each admission in 
HES with the Department of Health Payment by Results 
National Tariffs for the appropriate financial year27–36; see 
online supplementary appendix A for more details.
International comparisons
A search of MEDLINE and the Cumulative Index of Nursing 
and Allied Health (CINAHL) databases was conducted for 
the terms ‘acromioplasty’ or ‘subacromial decompression’ 
in conjunction with ‘incidence’ or ‘prevalence’ or ‘epide-
miology’. One author (TJ) screened the results for articles 
including rates of subacromial decompression contempo-
rary with our data, and further screened cited articles within 
included studies, as well as articles which cited included 
studies.
All statistical analyses were conducted using Stata/MP 14.2 
for Windows and we mapped variation in procedure rates 
across England in 2016/2017 using ArcGIS ArcMap 10.5.1 
for Desktop.
Patient and public involvement
There was no patient involvement in the design or conduct 
of this study. Two patients involved in the CSAW trial reviewed 
this manuscript; they were interested by the results and the 
cost-focussed perspective.
reSultS
the use of subacromial decompression in england
There were 15 112 subacromial decompression procedures 
(30 per 100 000 population) in 2007/2008, rising to 28 802 
procedures (52 per 100 000 population) in 2016/2017 
(figure 2), excluding those done in combination with rotator 
cuff repair. This represents a 91% increase in the number 
of subacromial decompressions over 10 years, with 266 692 
procedures carried out in total. Most of this increase took 
place before 2011/2012, and procedure rates have slightly 
decreased between 2011/2012 and 2016/2017. While the 
gender balance and age of those having shoulder surgery 
have remained steady over the last decade, the proportion 
of procedures conducted as day cases, using arthroscopy, 
and/or by independent (ie, non-NHS) providers, have all 
increased (table 1).
the cost of subacromial decompression in england
In 2016/2017, the median cost of an elective admission 
for subacromial decompression alone was £4476. The 
cost of subacromial decompression in England rose from 
£33 million in 2007/2008 to £125 million in 2016/2017. 
Over the 10-year period between 2007/2008 and 2016/2017 
just under £1.1 billion was spent on subacromial decom-
pression (excluding procedures done in combination with 
rotator cuff repair).
Variation in use of subacromial decompression in england
In 2016/2017 there was substantial variation in procedure 
rates between CCGs, after adjusting for age, sex, deprivation 
and ethnicity profiles (figure 3). The map demonstrates 
pockets of very high use (>150% of the expected rate), for 
example in the Reading area, Wiltshire and East Lincoln-
shire. There were also areas where procedure rates were less 
than 50% of the expected rate, such as in Worcestershire, 
Gloucestershire, Swindon and North Norfolk. In 2016/2017 
the ratio of procedure rates between a 'high use' CCG at 
the 90th percentile and a 'low use' CCG at the 10th percen-
tile was 2.7 (95% CI: 2.2 to 3.4). This ratio is lower than the 
2007/2008 ratio of 3.6 (95% CI: 2.2 to 6.1), although over-
lapping CIs suggest this may be due to chance variation; see 
table 2.
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Figure 3 Indirectly standardised rates of subacromial 
decompression by clinicalcommissioning group in England, 
2016/2017.
Table 2 90th/10th percentile ratios for directly age-sex 
standardised rates of subacromial decompression by 
clinicalcommissioning group, England, 2007/2008 to 
2016/2017
Year
90th 
percentile
10th 
percentile
90th/10th ratio 
(95% CI*)
2007/08 53 15 3.6 (2.2 to 6.1)
2008/09 55 16 3.3 (2.1 to 5.2)
2009/10 72 27 2.6 (2.0 to 3.5)
2010/11 87 33 2.6 (1.9 to 3.6)
2011/12 89 36 2.5 (2.0 to 3.1)
2012/13 90 33 2.7 (2.0 to 3.7)
2013/14 88 34 2.6 (2.1 to 3.3)
2014/15 89 33 2.7 (2.0 to 3.7)
2015/16 81 33 2.5 (1.4 to 4.3)
2016/17 83 30 2.7 (2.2 to 3.4)
*Confidence intervals for rate ratios.61
Table 3 International comparisons of age-sex-standardised 
rates of subacromial decompression
Article Country Data year
SAD rate 
(per 100 000 
population)
Thorpe et al37 Western 
Australia
2013 ~115
Paloneva et 
al39
Finland 2011 131
Vitale et al40 New York State 2006 102
Iyengar et al38 Florida State 2007 ~130
Our Data England 2016/17 52
Numbers for Thorpe et al and Iyengar et al38 were estimated from 
a graph; New York State data is for subacromial decompression 
with/without rotator cuff repair.
SAD, subacromial decompression.37–40
International comparison of rates of subacromial decompression
Table 3 shows rates of subacromial decompression in the 
most recent year available from England, Finland, Florida 
State, New York State and Western Australia. Rates in 
England were lower, often only half, that of other coun-
tries. For subacromial decompression alone, the procedure 
rates were lower in England (52 per 100 000 in 2016/2017) 
than Western Australia (roughly 115 per 100 000 in 2013),37 
Florida State (130 per 100 000 in 2007)38 and Finland (131 
per 100 000 in 2011).39
Figure 2 compares trends in rates of subacromial decom-
pression in England, Finland, Florida State, New York State 
and Western Australia. The rate of increase for subacro-
mial decompression observed in our study (x2 between 
2007/2008 and 2016/2017) was similar to Western Australia 
(x2 between 2001 and 2013),37 Finland (x2.2 between 1998 
and 2007)39 and New York State (x2.5 between 1996 and 
2006),40 but lower than Florida State (x4.4 between 2003 and 
2007).38 The use of subacromial decompression in Finland 
peaked in 2007 and has since been declining, at least in 
publicly-funded hospitals, which has been attributed to accu-
mulating evidence that it is no more clinically effective than 
non-surgical alternatives.39
DISCuSSIOn
Statement of principal findings
NHS England carries out nearly 30 000 subacromial decom-
pression operations per year, at an annual cost of over 
£125 million. Between 2007/2008 and 2016/2017, 266 692 
subacromial decompression procedures were carried out 
in England costing nearly £1.1 billion, before the addition 
of the CSAW and FIMPACT placebo-controlled trial results 
to the existing evidence prompted serious questions about 
the clinical benefit of the procedure. Rates of subacromial 
decompression alone in England have gradually declined 
since 2011/2012, although an increasing number are 
carried out in combination with rotator cuff repair. There 
was large variation between CCGs in England, even after 
adjustment for demographic variables, with ‘high-use’ areas 
carrying out nearly three times as many procedures as ‘low-
use’ areas. Procedure rates in England were notably lower 
than other countries, arguing against any levelling of proce-
dure rates being due to saturation of ‘demand’ for shoulder 
surgery.
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Strengths and weaknesses of the study
Our study used a national, longitudinal data set over a 
10-year period covering all NHS secondary care providers in 
England. Hospital Episode Statistics are administrative rather 
than specifically designed for research. However, HES is also 
linked to payments for hospitals, which is a strong incen-
tive to provide complete data, and allowed us to produce 
what we believe is the first exploration of costs associated 
with subacromial decompression in England. Payment by 
results tariffs are based on average national costs and may 
not reflect precise costs for each hospital admission. Popu-
lation denominators, and linkage to the indices of multiple 
deprivation and census ethnicity data, allowed us to investi-
gate trends and variations in procedure rates standardised 
on age, sex, deprivation and ethnicity. HES data records 
patients' area of residence, so we compared procedure rates 
based on place of residence rather than place of treatment. 
There may be other factors influencing rates which we have 
not controlled for (eg, private health insurance coverage). 
HES does not record procedures which are privately funded 
and provided, meaning our surgery rates are an underesti-
mate of the population rate. We only provide cost data from 
2007/2008 onwards, so we underestimate the amount spent 
on subacromial decompression prior to publication of the 
CSAW and FIMPACT trial results. International estima-
tions of procedure rates do not use identical definitions of 
procedures and inclusion/exclusion criteria, but should be 
broadly comparable.
Implications for policymakers and clinicians
NHS England spent over £1 billion on subacromial decom-
pression during the last 10 years without having compelling 
evidence of clinical effectiveness or cost-effectiveness. Rates 
of subacromial decompression were already rising rapidly 
from 2000/2001 onwards.13 It seems plausible that increasing 
awareness of concerns about the effectiveness of subacromial 
decompression surgery15–17 and well-known recruitment to 
the CSAW trial tempered the rise in use of this surgery in 
England, otherwise more may have been spent. The CSAW 
trial involved 51 surgeons in 30 centres throughout the UK 
and was widely advertised and discussed among shoulder 
surgeons and shoulder physiotherapists. Extensive consulta-
tion was carried out by the trial team prior to and during the 
trial, including presentations at national meetings surveys 
and visits to individual surgeons and centres.41 A similar 
plateau/decrease in procedures was observed in Finland 
after the commencement of the FIMPACT study in 2005 
which involved only three centres in Finland (figure 2). It 
is likely that awareness of a potential lack of effectiveness 
of subacromial decompression had been growing in the 
years before CSAW and FIMPACT, based on earlier trial 
results.15–17 However, it took well over a decade of increasing 
subacromial decompression use for clinical trial groups to 
run high quality, low risk-of-bias, placebo-controlled studies 
randomising a few hundred patients (313 patients for 
CSAW18 and 210 in FIMPACT19 to investigate its effectiveness. 
This delay may be due to perceived difficulties in recruiting 
patients to surgical trials with non-surgical comparators (eg, 
UKUFF,42 as well as known challenges of conducting surgical 
RCTs.43 Methods to optimise recruitment, as used in CSAW 
and other trials,44 are available to support the completion 
of such ‘difficult’ trials45; this should not now be a barrier 
to rapidly initiating trials to provide robust evidence about 
surgical interventions before they become widespread. More 
time is needed to see the longer-term impact of publication 
of the CSAW and FIMPACT results on subacromial decom-
pression rates, both in the UK and internationally.
The NICE requires evidence of cost-effectiveness to recom-
mend new medicines to be paid for by the NHS. It is unclear 
why the bar for introducing expensive surgical procedures 
should be significantly lower. A balance needs to be struck 
between supporting innovation in surgical procedures and 
preventing unnecessary treatment. New initiatives such 
as IDEAL (Idea, Development, Exploration, Assessment, 
Long-term Follow-up, Improving the Quality of Research in 
Surgery)46 aim to provide such a regulatory framework for 
introducing new interventions.
It is important that new evidence is disseminated quickly 
without causing inequities in access to care. NICE published 
an updated Clinical Knowledge Summary for shoulder pain 
in April 201747 incorporating information from a commis-
sioning guide published by the Royal College of Surgeons.48 
This recommended a range of conservative treatments 
from physiotherapy to corticosteroid injections, before 
surgery. However, many CCGs introduced their own crite-
ria-based policies for access to shoulder surgery (eg, through 
Individual Funding Requests),49 essentially meaning that 
commissioners would only pay providers for surgery under 
particular circumstances. These were implemented at 
different times and with different details, underlining the 
extent to which insufficient evidence may drive clinical and 
commissioner uncertainty,50 and possibly leading to the wide 
variations shown across CCGs in our data. Where scientific 
evidence is applicable nationally or internationally, it would 
seem more efficient and appropriate to apply national poli-
cies to inform optimal use and encourage further research. 
There is a need to improve techniques for empirically-in-
formed policy development in collaboration with relevant 
stakeholders.51 52
Despite the criticisms provided above, England has lower 
rates of shoulder surgery than other countries. The reasons 
for this are uncertain but could be due to differences in 
the health systems (eg, general practitioner gatekeeping 
of services), access to surgery and hospital reimbursement. 
Additionally, the National Institute of Health Research 
in England has funded major clinical trials on shoulder 
surgery,18 42 as well as other procedures53 54; and is about to 
fund a further clinical trial to compare surgery with placebo 
surgery for partial thickness rotator cuff tears.55 While the 
UK’s national regulatory processes are imperfect, they may 
provide examples to learn from. However, these processes 
did not sufficiently constrain the use of subacromial decom-
pression, a procedure later found to have little clinical 
benefit.
There have been several other controversies regarding 
the lack of effectiveness of procedures which have become 
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commonplace. One example is the use of stents to open 
narrowed arteries for treatment of stable angina (chest 
pain). Around half a million people receive stents for stable 
angina each year in the USA and Europe,56 but a recent 
(RCT) including a placebo intervention found no differ-
ence in chest pain outcomes between inserting a stent and 
using standard medications.57 Another example is arthros-
copy to clean out the knee joint, on which around $4 billion 
is spent each year in the USA.58 Recent RCTs,59 60 including 
one using a placebo procedure as a comparison,60 found no 
evidence of effectiveness to justify the spending. While we 
use subacromial decompression as an example in this study, 
our observations are likely to apply to interventional proce-
dures more generally.
unanswered questions and future research
The example of subacromial decompression highlights that, 
in the absence of rigorous evaluation, costly interventions 
can proliferate over a long period of time. To maximise 
limited resources, it is vital that methods are developed to 
identify promising procedures early and commission trials to 
examine their value, as well as identify existing health tech-
nologies that may be ineffective, leading to overtreatment 
and wasting of resources.
There is an opportunity for a natural experiment exploring 
the impact of the results of the CSAW and FIMPACT trials18 19 
on the development of CCG policies, national guidelines 
and clinical decision-making with surgeons and patients. It is 
arguable that we should now see swift reductions in the use 
of subacromial decompression; research studies could help 
enhance the transfer of knowledge from trials into clinical 
practice.
COnCluSIOnS
NHS England pays for nearly 30 000 shoulder subacromial 
decompression procedures each year at an annual cost of 
over £125 million, with little evidence that they are effective 
or cost-effective. The rates of this operation in other coun-
tries are even higher. This raises serious questions around 
the regulatory and professional processes governing the 
adoption and widespread use of surgical interventions. 
High quality RCTs should be funded early to examine the 
effectiveness and cost-effectiveness of expensive proce-
dures using methods to optimise recruitment, and robust 
processes should be developed to reduce the use of ineffec-
tive procedures.
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